The Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering is a part-time programme running for a minimum of 18 months over 2 academic years (maximum 45 months over 5 academic years) from the date of first registration for the programme.
Candidates must hold an NFQ Level 8 Degree in Engineering or equivalent, or an NFQ Level 8 BSc degree or equivalent, ideally with some relevant industrial experience. In all cases, the course of study for each candidate must be approved by the Programme Co-ordinator.
Students take modules to the value of 60 credits. Taught modules will be offered on a cyclical basis as detailed below. The choice of modules is subject to the approval of the Programme Coordinator.
Students select 60 credits
from the following:
Offered in 2016/17
CM6010 Introductory Pharmaceutical Chemistry
(5 credits)
PE6016 Pharmaceutical Industry; Manufacturing and Optimisation
(5 credits)
PE6018 Pharmaceutical Process Validation and Quality (5
credits)
PE6022 Aseptic Manufacturing Design (5 credits)
PE6024 Advanced Process Design & Safety
Engineering (5 credits)
PE6025 Advanced Health and Safety Management (5 credits)
PE6026 Project Engineering - From Concept to Completion (5 credits)
PF6302 Introduction to Pharmaceutics: Formulation Science (5
credits)
Offered in 2017/18
PE6010 Pharmaceutical Engineering
(5 credits)
PE6011 Biopharmaceutical Engineering
(5 credits)
PE6012 Pharmaceutical Process Equipment, Materials and Mechanical Design (5
credits)
PE6013 Powder and Particle Technology and Unit Operations (5 credits)
PE6015 Environmental Engineering in the Pharmaceutical Sector (5 credits)
PE6019 Process Analytical Technology (5 credits)
PE6023 Pharmaceutical and Biopharmaceutical Utilities (5 credits)
Examinations
Full details and regulations governing Examinations for each programme
will be contained in the Marks and Standards 2017 Book and for
each module in the Book of Modules
2016/2017.
MEngSc (Pharmaceutical and Biopharmaceutical Engineering)
Students who pass (40%) each of the taught modules in Year 1 and Year
2 examinations of the Postgraduate Diploma in Pharmaceutical and
Biopharmaceutical Engineering, and achieve an aggregate of at least
50% across all modules to the value of 60 credits at the first
attempt, are deemed eligible to apply for transfer to the MEngSc
(Pharmaceutical and Biopharmaceutical Engineering). Students who opt
to transfer to the MEngSc will not be conferred with the Postgraduate
Diploma.
Individual Modules
Candidates who satisfy the programme eligibility criteria may, subject
to the approval of the Programme Coordinator, be permitted to take
individual modules, as part of UCC's commitment to Continuing
Professional Development (CPD), and be provided with a relevant
transcript of marks.
Programme Learning Outcomes for Postgraduate Diploma in
Pharmaceutical and Biopharmaceutical Engineering
On successful completion of this programme, students should be able
to: